| Financial Year |
March 31 2023 |
| Monetary Funds |
243,900,829.63 |
| Held-for-trading Financial Assets |
720,000,000.00 |
| Notes Receivable |
6,716,962.94 |
| Accounts Receivable |
215,176,442.73 |
| Advances to Suppliers |
4,307,431.04 |
| Other Receivables |
4,471,411.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
120,094,038.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,594,118.57 |
| Total Current Assets |
1,365,985,275.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
124,957,009.69 |
| Under-construction Projects |
7,150,129.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,555,696.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,002,847.79 |
| Deferred Income Tax Assets |
5,086,521.85 |
| Other Non-Current Assets |
2,058,611.71 |
| Sub-Total of Non-Current Assets |
235,349,478.86 |
| Total Assets |
1,601,334,753.88 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
46,779,460.87 |
| Accounts Payable |
121,669,645.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,196,224.58 |
| Taxes Payable |
13,884,966.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,184,137.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,999,660.12 |
| Other Current Liabilities |
1,122,623.20 |
| Sub-Total of Current Liabilities |
258,081,952.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
61,141.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,247,724.65 |
| Total Liabilities |
279,329,676.67 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
785,117,685.56 |
| Surplus Reserve |
49,726,267.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
362,865,926.97 |
| Minority Stockholder's Interest |
4,276,012.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,317,729,064.93 |
| Owner's Equity（Stockholder's Equity） |
1,322,005,077.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,601,334,753.88 |
